▶ 調査レポート

滲出型加齢黄斑変性(AMD)の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Wet Age Related Macular Degeneration (AMD) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。滲出型加齢黄斑変性(AMD)の世界市場2020年:企業別、地域別、種類・用途別 / Global Wet Age Related Macular Degeneration (AMD) Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-02999資料のイメージです。• レポートコード:D0GIR-02999
• 出版社/出版日:GlobalInfoResearch / 2020年9月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、滲出型加齢黄斑変性(AMD)の世界市場を広く調査・分析し、今後の市場展望をまとめております。滲出型加齢黄斑変性(AMD)の種類別市場規模(湿性滲出型加齢黄斑変性(Wet AMD)、乾性滲出型加齢黄斑変性(Dry AMD))、用途別市場規模(75年以上、60年以上、40年以上)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Novartis International (Switzerland)、StemCell (Canada)、Neurotech Pharmaceuticals (US)、Bayer (Germany)、Alimera Sciences (US)、Acucela (US)、Regeneron Pharmaceutical (US)、GlaxoSmithKline (US)、Ophthotech (US)、F. Hoffmann-La Roche (Switzerland)、Allergan (Ireland)、Adverum Biotechnologies (US)、Gilead Sciences (US)
・地域別グローバル市場分析 2015年-2020年
・滲出型加齢黄斑変性(AMD)の北米市場(アメリカ、カナダ、メキシコ)
・滲出型加齢黄斑変性(AMD)のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・滲出型加齢黄斑変性(AMD)のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・滲出型加齢黄斑変性(AMD)の南米市場(ブラジル、アルゼンチン)
・滲出型加齢黄斑変性(AMD)の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:湿性滲出型加齢黄斑変性(Wet AMD)、乾性滲出型加齢黄斑変性(Dry AMD)
・用途別分析:75年以上、60年以上、40年以上
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Wet Age Related Macular Degeneration (AMD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Wet Age Related Macular Degeneration (AMD) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Wet Age Related Macular Degeneration (AMD) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Wet Age Related Macular Degeneration (AMD) market has been segmented into:
Wet Age-Related Macular Degeneration (Wet AMD)
Dry Age-Related Macular Degeneration (Dry AMD)

By Application, Wet Age Related Macular Degeneration (AMD) has been segmented into:
Above 75 Years
Above 60 Years
Above 40 Years

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Wet Age Related Macular Degeneration (AMD) market presented in the report. This section sheds light on the sales growth of different regional and country-level Wet Age Related Macular Degeneration (AMD) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Wet Age Related Macular Degeneration (AMD) market.

The report offers in-depth assessment of the growth and other aspects of the Wet Age Related Macular Degeneration (AMD) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Wet Age Related Macular Degeneration (AMD) Market Share Analysis
Wet Age Related Macular Degeneration (AMD) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Wet Age Related Macular Degeneration (AMD) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Wet Age Related Macular Degeneration (AMD) sales, revenue and market share for each player covered in this report.

The major players covered in Wet Age Related Macular Degeneration (AMD) are:
Novartis International (Switzerland)
StemCell (Canada)
Neurotech Pharmaceuticals (US)
Bayer (Germany)
Alimera Sciences (US)
Acucela (US)
Regeneron Pharmaceutical (US)
GlaxoSmithKline (US)
Ophthotech (US)
F. Hoffmann-La Roche (Switzerland)
Allergan (Ireland)
Adverum Biotechnologies (US)
Gilead Sciences (US)

レポート目次

Table of Contents

1 Wet Age Related Macular Degeneration (AMD) Market Overview
1.1 Product Overview and Scope of Wet Age Related Macular Degeneration (AMD)
1.2 Classification of Wet Age Related Macular Degeneration (AMD) by Type
1.2.1 Global Wet Age Related Macular Degeneration (AMD) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type in 2019
1.2.3 Wet Age-Related Macular Degeneration (Wet AMD)
1.2.4 Dry Age-Related Macular Degeneration (Dry AMD)
1.3 Global Wet Age Related Macular Degeneration (AMD) Market by Application
1.3.1 Overview: Global Wet Age Related Macular Degeneration (AMD) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Above 75 Years
1.3.3 Above 60 Years
1.3.4 Above 40 Years
1.4 Global Wet Age Related Macular Degeneration (AMD) Market by Regions
1.4.1 Global Wet Age Related Macular Degeneration (AMD) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Wet Age Related Macular Degeneration (AMD) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Wet Age Related Macular Degeneration (AMD) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis International (Switzerland)
2.1.1 Novartis International (Switzerland) Details
2.1.2 Novartis International (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis International (Switzerland) SWOT Analysis
2.1.4 Novartis International (Switzerland) Product and Services
2.1.5 Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.2 StemCell (Canada)
2.2.1 StemCell (Canada) Details
2.2.2 StemCell (Canada) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 StemCell (Canada) SWOT Analysis
2.2.4 StemCell (Canada) Product and Services
2.2.5 StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Neurotech Pharmaceuticals (US)
2.3.1 Neurotech Pharmaceuticals (US) Details
2.3.2 Neurotech Pharmaceuticals (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Neurotech Pharmaceuticals (US) SWOT Analysis
2.3.4 Neurotech Pharmaceuticals (US) Product and Services
2.3.5 Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer (Germany)
2.4.1 Bayer (Germany) Details
2.4.2 Bayer (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer (Germany) SWOT Analysis
2.4.4 Bayer (Germany) Product and Services
2.4.5 Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Alimera Sciences (US)
2.5.1 Alimera Sciences (US) Details
2.5.2 Alimera Sciences (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Alimera Sciences (US) SWOT Analysis
2.5.4 Alimera Sciences (US) Product and Services
2.5.5 Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Acucela (US)
2.6.1 Acucela (US) Details
2.6.2 Acucela (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Acucela (US) SWOT Analysis
2.6.4 Acucela (US) Product and Services
2.6.5 Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Regeneron Pharmaceutical (US)
2.7.1 Regeneron Pharmaceutical (US) Details
2.7.2 Regeneron Pharmaceutical (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Regeneron Pharmaceutical (US) SWOT Analysis
2.7.4 Regeneron Pharmaceutical (US) Product and Services
2.7.5 Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline (US)
2.8.1 GlaxoSmithKline (US) Details
2.8.2 GlaxoSmithKline (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline (US) SWOT Analysis
2.8.4 GlaxoSmithKline (US) Product and Services
2.8.5 GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Ophthotech (US)
2.9.1 Ophthotech (US) Details
2.9.2 Ophthotech (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Ophthotech (US) SWOT Analysis
2.9.4 Ophthotech (US) Product and Services
2.9.5 Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.10 F. Hoffmann-La Roche (Switzerland)
2.10.1 F. Hoffmann-La Roche (Switzerland) Details
2.10.2 F. Hoffmann-La Roche (Switzerland) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 F. Hoffmann-La Roche (Switzerland) SWOT Analysis
2.10.4 F. Hoffmann-La Roche (Switzerland) Product and Services
2.10.5 F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Allergan (Ireland)
2.11.1 Allergan (Ireland) Details
2.11.2 Allergan (Ireland) Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Allergan (Ireland) SWOT Analysis
2.11.4 Allergan (Ireland) Product and Services
2.11.5 Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Adverum Biotechnologies (US)
2.12.1 Adverum Biotechnologies (US) Details
2.12.2 Adverum Biotechnologies (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Adverum Biotechnologies (US) SWOT Analysis
2.12.4 Adverum Biotechnologies (US) Product and Services
2.12.5 Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Gilead Sciences (US)
2.13.1 Gilead Sciences (US) Details
2.13.2 Gilead Sciences (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Gilead Sciences (US) SWOT Analysis
2.13.4 Gilead Sciences (US) Product and Services
2.13.5 Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Wet Age Related Macular Degeneration (AMD) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Wet Age Related Macular Degeneration (AMD) Players Market Share
3.2.2 Top 10 Wet Age Related Macular Degeneration (AMD) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Wet Age Related Macular Degeneration (AMD) Revenue and Market Share by Regions
4.2 North America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.3 Europe Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.5 South America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5 North America Wet Age Related Macular Degeneration (AMD) Revenue by Countries
5.1 North America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
5.2 USA Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5.3 Canada Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
5.4 Mexico Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6 Europe Wet Age Related Macular Degeneration (AMD) Revenue by Countries
6.1 Europe Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
6.2 Germany Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.3 UK Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.4 France Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.5 Russia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
6.6 Italy Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue by Countries
7.1 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
7.2 China Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.3 Japan Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.4 Korea Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.5 India Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8 South America Wet Age Related Macular Degeneration (AMD) Revenue by Countries
8.1 South America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
8.2 Brazil Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
8.3 Argentina Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Wet Age Related Macular Degeneration (AMD) by Countries
9.1 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.3 UAE Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.4 Egypt Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
9.5 South Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Wet Age Related Macular Degeneration (AMD) Revenue and Market Share by Type (2015-2020)
10.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Type (2019-2024)
10.3 Wet Age-Related Macular Degeneration (Wet AMD) Revenue Growth Rate (2015-2025)
10.4 Dry Age-Related Macular Degeneration (Dry AMD) Revenue Growth Rate (2015-2025)
11 Global Wet Age Related Macular Degeneration (AMD) Market Segment by Application
11.1 Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2015-2020)
11.2 Wet Age Related Macular Degeneration (AMD) Market Forecast by Application (2019-2024)
11.3 Above 75 Years Revenue Growth (2015-2020)
11.4 Above 60 Years Revenue Growth (2015-2020)
11.5 Above 40 Years Revenue Growth (2015-2020)
12 Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2025)
12.1 Global Wet Age Related Macular Degeneration (AMD) Market Size Forecast (2021-2025)
12.2 Global Wet Age Related Macular Degeneration (AMD) Market Forecast by Regions (2021-2025)
12.3 North America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.4 Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.6 South America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Wet Age Related Macular Degeneration (AMD) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Wet Age Related Macular Degeneration (AMD) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Wet Age Related Macular Degeneration (AMD) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis International (Switzerland) Corporate Information, Location and Competitors
Table 6. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Major Business
Table 7. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 8. Novartis International (Switzerland) SWOT Analysis
Table 9. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 10. Novartis International (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. StemCell (Canada) Corporate Information, Location and Competitors
Table 12. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Major Business
Table 13. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2018-2019)
Table 14. StemCell (Canada) SWOT Analysis
Table 15. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 16. StemCell (Canada) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Neurotech Pharmaceuticals (US) Corporate Information, Location and Competitors
Table 18. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 19. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 20. Neurotech Pharmaceuticals (US) SWOT Analysis
Table 21. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 22. Neurotech Pharmaceuticals (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer (Germany) Corporate Information, Location and Competitors
Table 24. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Major Business
Table 25. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 26. Bayer (Germany) SWOT Analysis
Table 27. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 28. Bayer (Germany) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Alimera Sciences (US) Corporate Information, Location and Competitors
Table 30. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 31. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 32. Alimera Sciences (US) SWOT Analysis
Table 33. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 34. Alimera Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Acucela (US) Corporate Information, Location and Competitors
Table 36. Acucela (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 37. Acucela (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 38. Acucela (US) SWOT Analysis
Table 39. Acucela (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 40. Acucela (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Regeneron Pharmaceutical (US) Corporate Information, Location and Competitors
Table 42. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 43. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 44. Regeneron Pharmaceutical (US) SWOT Analysis
Table 45. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 46. Regeneron Pharmaceutical (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GlaxoSmithKline (US) Corporate Information, Location and Competitors
Table 48. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 49. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 50. GlaxoSmithKline (US) SWOT Analysis
Table 51. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 52. GlaxoSmithKline (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Ophthotech (US) Corporate Information, Location and Competitors
Table 54. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 55. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 56. Ophthotech (US) SWOT Analysis
Table 57. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 58. Ophthotech (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. F. Hoffmann-La Roche (Switzerland) Corporate Information, Location and Competitors
Table 60. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Major Business
Table 61. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 62. F. Hoffmann-La Roche (Switzerland) SWOT Analysis
Table 63. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 64. F. Hoffmann-La Roche (Switzerland) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Allergan (Ireland) Corporate Information, Location and Competitors
Table 66. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Major Business
Table 67. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 68. Allergan (Ireland) SWOT Analysis
Table 69. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 70. Allergan (Ireland) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Adverum Biotechnologies (US) Corporate Information, Location and Competitors
Table 72. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 73. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 74. Adverum Biotechnologies (US) SWOT Analysis
Table 75. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 76. Adverum Biotechnologies (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Gilead Sciences (US) Corporate Information, Location and Competitors
Table 78. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Major Business
Table 79. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Total Revenue (USD Million) (2017-2018)
Table 80. Gilead Sciences (US) SWOT Analysis
Table 81. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Product and Solutions
Table 82. Gilead Sciences (US) Wet Age Related Macular Degeneration (AMD) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Players (2015-2020)
Table 84. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players (2015-2020)
Table 85. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)
Table 87. North America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
Table 88. North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Table 89. Europe Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Wet Age Related Macular Degeneration (AMD) Revenue by Countries (2015-2020)
Table 92. South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Table 95. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) by Type (2015-2020)
Table 96. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Type (2015-2020)
Table 97. Global Wet Age Related Macular Degeneration (AMD) Revenue Forecast by Type (2021-2025)
Table 98. Global Wet Age Related Macular Degeneration (AMD) Revenue by Application (2015-2020)
Table 99. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Application (2015-2020)
Table 100. Global Wet Age Related Macular Degeneration (AMD) Revenue Forecast by Application (2021-2025)
Table 101. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Wet Age Related Macular Degeneration (AMD) Picture
Figure 2. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Type in 2019
Figure 3. Wet Age-Related Macular Degeneration (Wet AMD) Picture
Figure 4. Dry Age-Related Macular Degeneration (Dry AMD) Picture
Figure 5. Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Application in 2019
Figure 6. Above 75 Years Picture
Figure 7. Above 60 Years Picture
Figure 8. Above 40 Years Picture
Figure 9. Global Wet Age Related Macular Degeneration (AMD) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Wet Age Related Macular Degeneration (AMD) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Wet Age Related Macular Degeneration (AMD) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Regions in 2018
Figure 23. North America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 26. South America Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 28. North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 30. USA Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 35. Germany Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 36. UK Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 37. France Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 42. China Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 45. India Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 47. South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 49. Brazil Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Wet Age Related Macular Degeneration (AMD) Revenue and Growth Rate (2015-2020)
Figure 57. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Type (2015-2020)
Figure 58. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Type in 2019
Figure 59. Global Wet Age Related Macular Degeneration (AMD) Market Share Forecast by Type (2021-2025)
Figure 60. Global Wet Age-Related Macular Degeneration (Wet AMD) Revenue Growth Rate (2015-2020)
Figure 61. Global Dry Age-Related Macular Degeneration (Dry AMD) Revenue Growth Rate (2015-2020)
Figure 62. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Application (2015-2020)
Figure 63. Global Wet Age Related Macular Degeneration (AMD) Revenue Share by Application in 2019
Figure 64. Global Wet Age Related Macular Degeneration (AMD) Market Share Forecast by Application (2021-2025)
Figure 65. Global Above 75 Years Revenue Growth Rate (2015-2020)
Figure 66. Global Above 60 Years Revenue Growth Rate (2015-2020)
Figure 67. Global Above 40 Years Revenue Growth Rate (2015-2020)
Figure 68. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Wet Age Related Macular Degeneration (AMD) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Wet Age Related Macular Degeneration (AMD) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 72. Europe Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 74. South America Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Wet Age Related Macular Degeneration (AMD) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel